Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Olympus Corp Ord (OCPNF)

Olympus Corp Ord (OCPNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 20.09
  • Price/Book 3.91
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.0000 +2.59%
on 03/06/26
10.0500 -18.33%
on 02/20/26
-4.0925 (-33.27%)
since 02/06/26
3-Month
8.0000 +2.59%
on 03/06/26
13.2000 -37.82%
on 01/14/26
-3.7025 (-31.09%)
since 12/10/25
52-Week
8.0000 +2.59%
on 03/06/26
14.0000 -41.37%
on 11/12/25
-5.2325 (-38.93%)
since 03/10/25

Most Recent Stories

More News
EAGLE Trial Shows Olympus(R) CADDIE(TM) AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesions

EAGLE Trial Shows Olympus(R) CADDIE(TM) AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesions

OLYMY : 8.0900 (-2.29%)
OCPNF : 8.2075 (+2.59%)
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership

Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership

OLYMY : 8.0900 (-2.29%)
OCPNF : 8.2075 (+2.59%)
Olympus Unveils Corporate Strategy

Olympus Unveils Corporate Strategy

OLYMY : 8.0900 (-2.29%)
OCPNF : 8.2075 (+2.59%)
Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center

Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center

OLYMY : 8.0900 (-2.29%)
OCPNF : 8.2075 (+2.59%)
Olympus Launches New Surgical Energy Device for Hemostatic Cutting and Vessel Sealing

Olympus Launches New Surgical Energy Device for Hemostatic Cutting and Vessel Sealing

OLYMY : 8.0900 (-2.29%)
OCPNF : 8.2075 (+2.59%)
Olympus: "Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India" Selected for METI's FY2024 Supplementary "Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration /

Olympus: "Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India" Selected for METI's FY2024 Supplementary "Global South Future-Oriented Co-Creation Subsidy...

OLYMY : 8.0900 (-2.29%)
OCPNF : 8.2075 (+2.59%)
Macquarie Sticks to Its Hold Rating for Olympus (OCPNF)

In a report released today, Tony Ren from Macquarie maintained a Hold rating on Olympus, with a price target of Yen2,000.00. The company’s shares closed last Tuesday at $12.42.Elevate Your Investing...

OLYMY : 8.0900 (-2.29%)
OCPNF : 8.2075 (+2.59%)
Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device

Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device

OLYMY : 8.0900 (-2.29%)
OCPNF : 8.2075 (+2.59%)
Olympus (OCPNF) Receives a Buy from J.P. Morgan

In a report released today, Naoko Saito from J.P. Morgan maintained a Buy rating on Olympus, with a price target of Yen2,100.00. The company’s shares closed last Tuesday at $12.42.Elevate Your Investing...

OLYMY : 8.0900 (-2.29%)
OCPNF : 8.2075 (+2.59%)
Olympus Launches OLYSENSE CAD/AI in the US and Europe

Olympus Launches OLYSENSE CAD/AI in the US and Europe

OLYMY : 8.0900 (-2.29%)
OCPNF : 8.2075 (+2.59%)

Business Summary

Olympus Corp was incorporated in Japan on October 12, 1919. The Company is engaged in manufacturing and selling of precision machineries and instruments. The Company operates in four segments including Medical Business, Life Science and Industrial Business, Imaging Business, and Others. The Medical Business...

See More

Key Turning Points

3rd Resistance Point 8.2075
2nd Resistance Point 8.2075
1st Resistance Point 8.2075
Last Price 8.2075
1st Support Level 8.2075
2nd Support Level 8.2075
3rd Support Level 8.2075

See More

52-Week High 14.0000
Fibonacci 61.8% 11.7080
Fibonacci 50% 11.0000
Fibonacci 38.2% 10.2920
Last Price 8.2075
52-Week Low 8.0000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar